---
title: "EDICK PAUL R — Ownership Dossier"
canonical: https://whiteintel.dev/entity/4aa3d31f-7baa-55f8-80fe-022b7a61c9cc
json: https://whiteintel.dev/api/public/dossier/4aa3d31f-7baa-55f8-80fe-022b7a61c9cc
identifier: sec:0001531178
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# EDICK PAUL R

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001531178`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/4aa3d31f-7baa-55f8-80fe-022b7a61c9cc  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/4aa3d31f-7baa-55f8-80fe-022b7a61c9cc  

## Ownership & control

### Holdings / subsidiaries

- **Vistagen Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/07692e81-e223-5661-92a2-395c191a019b
- **Xeris Biopharma Holdings, Inc.** (director) — https://whiteintel.dev/entity/0ac3517f-98a5-5bae-ae70-e8209062d136
- **Xeris Biopharma Holdings, Inc.** (officer) — https://whiteintel.dev/entity/0ac3517f-98a5-5bae-ae70-e8209062d136
- **XERIS PHARMACEUTICALS INC** (officer) — https://whiteintel.dev/entity/3a535122-62e2-50b3-872c-5a949fba4f33
- **XERIS PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/3a535122-62e2-50b3-872c-5a949fba4f33
- **Milestone Pharmaceuticals Inc.** (director) — https://whiteintel.dev/entity/a6f815dd-2ef6-55ab-85ab-7f99a8cc3977
- **Iterum Therapeutics plc** (director) — https://whiteintel.dev/entity/9e861cbf-735d-52f2-a727-f5ac0e43740e
- **PDL BIOPHARMA, INC.** (director) — https://whiteintel.dev/entity/873cf799-8aef-5e83-b234-75654906dd0f
- **SUCAMPO PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/75b1919f-f0d2-5874-a261-194aabb57fa2
- **NEOS THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/fd7737cb-d6d9-51da-8a25-e379f1a3890f
- **LUMOS PHARMA, INC.** (director) — https://whiteintel.dev/entity/64076a09-cab0-5d69-bb5e-15a5eca2d879
- **DURATA THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/c9ad4838-557e-5e50-8482-6030f8b61325

…and **2** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **EDICK PAUL R** — https://whiteintel.dev/entity/4aa3d31f-7baa-55f8-80fe-022b7a61c9cc · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **EDICK PAUL R**. Human view: https://whiteintel.dev/entity/4aa3d31f-7baa-55f8-80fe-022b7a61c9cc · Structured JSON: https://whiteintel.dev/api/public/dossier/4aa3d31f-7baa-55f8-80fe-022b7a61c9cc._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._